DefinitionThis section has been translated automatically.
IndicationThis section has been translated automatically.
Symptomatic treatment of seasonal and perennial allergic rhinitis with or without allergic conjunctivitis, itching, to reduce the formation of new wheals in urticaria.
You might also be interested in
Pregnancy/nursing periodThis section has been translated automatically.
Should not be used during pregnancy (insufficient data available). Contraindicated during lactation (do not use, because due to insufficient data it is not known whether the active substance passes into breast milk).
Dosage and method of useThis section has been translated automatically.
- Allergic rhinitis: children > 12 years and adults: 1 x/day 10 mg p.o. In case of severe symptoms and perennial allergic rhinitis, increase the dose to 20 mg p.o. once/day.
- Urticaria: adults, adolescents > 18 years: once/day 10 mg p.o.
Undesirable effectsThis section has been translated automatically.
Occasionally or rarely headaches, fatigue, dry mouth, pharyngitis, abdominal pain, indigestion, weakness, nosebleeds, rhinitis, sinusitis, nausea, insomnia, etc.
InteractionsThis section has been translated automatically.
Ketoconazole or erythromycin: higher ebastine plasma levels and an increase of the QTc interval of about 10 msec longer than after the sole administration of ketoconazole or erythromycin.
ContraindicationThis section has been translated automatically.
Severe liver or kidney failure.
Notice!
Do not use on children or patients under 18 years of age (insufficient data available)!PreparationsThis section has been translated automatically.
Ebastel® 10 mg film-coated tablets, Ebastel® 20 mg film-coated tablets
Prof. Dr. med. Peter Altmeyer